Dubai, United Arab Emirates, 5th February 2025 – Stemz Global, a diversified group with businesses in Healthcare, Agriculture, and Manufacturing, and the largest visa medical services provider in Asia and the Middle East, has announced a strategic equity investment in DeepTek, a leader in AI-based Radiology solutions known for pioneering advanced imaging technologies that enhance diagnostic accuracy and efficiency. Alongside this investment, the two companies have entered into a collaboration to integrate AI-driven solutions, enhancing medical diagnostics and healthcare delivery for governments and healthcare institutions across the Middle East and Asia.

DeepTek is at the forefront of AI-powered medical imaging, providing FDA-cleared and globally recognized solutions that reduce radiologists’ workload, enhance diagnostic precision, and streamline clinical decision-making. With a footprint in 500+ hospitals and imaging centers worldwide, DeepTek’s AI-driven technologies are transforming healthcare by cutting diagnostic time and improving patient outcomes.

Driving the Future of AI in Healthcare

The partnership with Stemz Global reflects a shared vision of leveraging advanced technology to enhance healthcare services. Through this collaboration, AI-powered diagnostics will be integrated into government and private healthcare institutions, optimizing patient care and expanding telemedicine capabilities. By combining DeepTek’s expertise in AI-driven imaging solutions with Stemz Global’s extensive network in healthcare operations, this initiative aims to deliver faster, more accurate diagnoses, improve patient outcomes, and strengthen healthcare accessibility across multiple regions.

"AI is reshaping the future of healthcare," said Dr. Raman Sodhi, Founder, CEO & MD of Stemz Global. "This partnership strengthens our commitment to bringing cutting-edge AI advancements to the markets we serve. By integrating AI into medical diagnostics, we can enhance accuracy, efficiency, and accessibility - ultimately benefiting millions of patients worldwide."

Mr. Ajit Patil, Co-founder and MD of DeepTek, described the partnership as a pivotal milestone, stating:"Stemz Global’s investment marks a significant step toward making AI-driven radiology more impactful and accessible. By combining our AI expertise with Stemz’s vast healthcare operations, we are set to expand the reach of AI diagnostics, optimize patient outcomes, and advance telemedicine solutions globally."

What’s Next?

Stemz Global and DeepTek are poised to deploy AI-driven diagnostics in key hospitals and medical centers across multiple regions over the next year. The partnership will play a crucial role in helping governments and healthcare providers build resilient, tech-enabled healthcare systems that meet the growing demand for high-precision diagnostics.

"We deeply appreciate the trust placed in us by Dr. Raman Sodhi and Mr. Aman Bakhshi," added Mr. Ajit Patil. "We extend our gratitude to NTT DATA India for facilitating this collaboration. Together, we look forward to transforming healthcare through AI-driven innovation."

About Stemz Global

Stemz Global is a leading multinational group operating in Healthcare, Agriculture, and Manufacturing, with a strong presence across Asia, the Middle East, and beyond. As the largest visa medical services provider in the region, Stemz is committed to advancing healthcare accessibility, operational excellence, and technological innovation.

For more information, visit: www.stemzhealthcare.com

About DeepTek

DeepTek is a pioneer in AI-driven radiology solutions, transforming medical imaging through advanced machine learning algorithms. With US FDA clearance and global regulatory approvals, DeepTek’s solutions are deployed in 500+ hospitals and imaging centers, enhancing diagnostic speed and accuracy worldwide.